Cell line · CVCL_0201
Caov-3
Cancer cell line, Homo sapiens. High grade ovarian serous adenocarcinoma. 97 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. Caov-3. Cell lines, record CVCL_0201. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0201
On this page
Cell line
As Cellosaurus gives it.
- Name
- Caov-3
- Accession
- CVCL_0201
- RRID
- RRID:CVCL_0201
- Synonyms
- CaOv-3, CaOV-3, CAOV-3, CAOV3, CaOV3, CaOv3, Caov3, CA-OV-3, CaOV3 (S)
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 54Y
- Category
- Cancer cell line
- Diseases
- High grade ovarian serous adenocarcinoma (NCIt C105555)
- Derived from
- Ovary (in situ)
- Secondary accessions
- CVCL_0231
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers97
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Exosomal circ_0000387 Is Associated With Ovarian Cancer Metastatic Regulation Through IGF2BP3-Related Signalling and Endothelial VWF Responses. | J Biochem Mol Toxicol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Extracellular vesicle lipidomics liquid biopsy reveals systemic and tumor microenvironment metabolic reprogramming in ovarian cancer. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A membrane-penetrating modified ascites-derived peptide, TAT-CPAP1, sensitizes TP53 wild-type ovarian cancer cells to platinum-based therapy through targeting the NOLC1-MDM2/MDM4 axis. | Transl Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Nuclear localization of the glutaminyl-tRNA synthetase QARS reveals its role in DNA damage response in ovarian cancer. | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| KPNA2 Drives Immunosuppression in Ovarian Cancer via CCL2/CCR2-Dependent MDSC Recruitment. | Cancer Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The central precocious puberty-associated gene MKRN3 is a tumor suppressor regulating CSDE1 ubiquitination in ovarian cancer. | Oncogenesis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Absence of synergistic effects by CDK12/13 inhibition in combination with cisplatin or olaparib in ovarian cancer cells. | Sci Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| CBX2 phase-separation contributes to homologous recombination repair and drug resistance in ovarian cancer. | Cell Death Dis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Early-stage multi-cancer detection through a plasma extracellular vesicle protein signature. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Tumor-Infiltrating Nociceptor Neurons in Ovarian Cancer Treatment Resistance. | Adv Biol (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 97
See all 97 papersRelatives5
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | CA-CD437R | CVCL_4Y66 | Cell lines | |
| Derived from it | CAOV3 (R) | CVCL_C8XN | Cell lines | |
| Derived from it | CaOV3 CBPR | CVCL_E3AS | Cell lines | |
| Derived from it | Caov-3-Luc | CVCL_C8XM | Cell lines | |
| Derived from it | HyCyte Caov-3 stable cell line for hROR1 overexpression | CVCL_F4QI | Cell lines |
Cell banks7
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | HTB-75 | ATCC | |
| CCTCC | GDC0118 | Cellosaurus | |
| CLS | 300319 | CLS | |
| CancerTools | 161926 | CancerTools | |
| IZSLER | BS TCL 165 | Cellosaurus | |
| KCB | KCB 2013041YJ | Cellosaurus | |
| Ubigene | YC-C031 | Ubigene |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0201
GET https://conductscience.org/api/cell-lines/v1/CVCL_0201/papers?page=2